Mapping connectomes in disease?
Check out our article on clinical connectomics in @NeuroCellPress
- Tractography behavior in disease
- How to measure connectivity
- How pathology impacts each stage of connectome mapping
- Multiscale connectomics
https://t.co/u4CcFuPjPL
Aerobic exercise, intensive blood pressure and cholesterol reduction, or both did not show differences in cognitive function improvement over 24 months among older adults with family history of #dementia or subjective #cognitive decline.
https://t.co/nH3dncXeV5
🫀What is the relationship between adult cardiorespiratory fitness (CRF) and dementia risk? 🫀
Newly published research in #DADM demonstrate high CRF is longitudinally associated with a lower risk of late-onset dementia (🧵1/2)
Full Article: https://t.co/Z98Aauishw
#Delirium is not “just confusion”, it is a major prognostic event in CV medicine.
In our State-of-the-Art Review in #EHJ, we synthesize current evidence on mechanisms, prevention, and management across the CV continuum. 🧠🫀
https://t.co/l4VSzuTQDL
@CekajEndrit et al👏👏
🔥🔥Exciting news!!!🔥🔥
The invited speaker schedule for the 2026 Noosa Brain Workshop has been finalised!
Commuter registrations are still available, but close Feb 1.
3 more weeks to get in!!!
Register here:
https://t.co/J37Kv1JoK2
Togo et al. show strong electrophysiological links between the hippocampus and both the anterior and posterior thalamus, along with robust connections between thalamic subregions. https://t.co/cx0isOqkCe; https://t.co/yWIf8Jufjq
Exciting announcement!
Our Institute is calling for applications for a EMCR 2-year fellowship .
Come and join a great team @turnerinstitute!
Details here:
https://t.co/I2QjJuTNbW
Yet more evidence that haloperidol is not a sedative.
RCT to ⬇️ agitation in palliative care #delirium
1⃣haloperidol
2⃣lorazepam
3⃣halop + loraz
4⃣placebo
Haloperidol monotherapy was not more efficacious than placebo in reducing RASS.
https://t.co/ceA2P4Oj6y
The VasCog-2-WSO criteria provide updated international guidelines for diagnosing vascular cognitive impairment and #dementia, incorporating recent biomarker advancements. https://t.co/2KLr8NTQgr
We reassessed the @TheLancet 14 dementia risk factors and added poverty, wealth shocks, income inequality, & HIV. This provides a larger estimation of preventable dementia & exposes gender inequities with larger burdens in women. Out in @eBioMedicine https://t.co/kBb58VbPdO. Great leadership of Cyprian Mostert and congrats all authors: @MomohChi , Andrea Sylvia Winkler, Connor McLaughlin, @HarrisAEyre , @Mohamed03966736, Kirti Ranchod, @DominicTrepel , @vradenburg3 , William Hynes,@FiegsZA , Shehzad Ali, Najat E. L. Mekkaoui, Alan Landay, @dr_bobrow, @levi_muyela, Kelly Atkins, @ChadhaAnt, @r_marongiu, @PaolaBarbato, @sam_nightinga1e, John Joska, Alfred K. Njamnshi, Mie Rizig, @JamesGKahn1, Karen Blackmon, Zul Merali
A privilege to represent the population health perspective, alongside Carol Brayne @CamPubHealth , in this new @TheLancet Series on Alzheimer's disease. Expertly led by @GiovanniFrisoni
Alzheimer's disease outlook: controversies and future directions https://t.co/keHNojvBYN
New paper in Imaging Neuroscience by Sian Virtue-Griffiths, Nigel C. Rogasch, et al:
Task-related changes in aperiodic activity are related to visual working memory capacity independent of event-related potentials and alpha oscillations
https://t.co/49vv4NUxaZ
The VasCog-2-WSO criteria provide updated international guidelines for diagnosing vascular cognitive impairment and #dementia, incorporating recent biomarker advancements. https://t.co/X0D2xZ8Zx8
Prehabilitation Program for Older Adults Undergoing Major Elective Surgery:
Individualized physical therapy, nutritional counseling with protein supplementation, and guided meditation for 3–4 weeks before major surgery
https://t.co/Q2TUmkRL4Z
Team Leader: Technical Services position now open!
Come work with us on EEG, PSG and VR research studies. The role will support psychology researchers at the new Adelaide University 🧠
https://t.co/x5XAuMOV0l